This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Posttransfusion Purpura
Information about Posttransfusion Purpura: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Posttransfusion Purpura
Most recent studies have shown that Posttransfusion Purpura shares some biological mechanisms with alloimmunization, autoimmune-reaction, carcinoma, cell-transformation-neoplastic, depressive-disorder, diabetes-mellitus, diabetes-mellitus-non-insulin-dependent, edema, hemorrhage, insulin-resistance, malignant-neoplasms, neonatal-alloimmune-thrombocytopenia, neoplasms, nervousness, obesity, purpura, tetanus, thrombocytopenic-purpura, tissue-adhesions.
Among the many pathways, these few ones have gauged particular interests from scientists studying Posttransfusion Purpura, and have been seen in publications frequently: Aging, Cell Activation, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Dna Replication, Immune Response, Localization, Mitochondrial Depolarization, Oxidative Phosphorylation, Pathogenesis, Platelet Aggregation, Protein Phosphorylation, Secretion, Sensitization, Synaptic Transmission, Transport
Quite a number of genes have been found to play important roles in Posttransfusion Purpura, such as CYCS, EGFR, INS, INSR, MAPK1, MAPK3, PTK2B, PTPN1, PTPN11, PTPN2, PTPN6, PTPRA, PTPRC, PTPRF, PTPRU, REG1A, SLC25A3, SRC, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.